Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04699279 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)

Study acronym: PANDA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 13, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 3 of 5 sitesv6
  2. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024
    • Study sites: 2 to 5
    • Collaborators: 1 to 4
    • Study title expanded, about 9 words
    v5
  3. Study title shortened, about 1 wordv4
  4. Study sites: 1 to 2
    • Eligibility criteria expanded, about 1 word
    • Collaborators expanded, about 3 words
    • Study title expanded, about 1 word
    v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Acute Aortic Syndrome (AAS)/Aortic Aneurysm is a common feature of aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, the authors hypothesized that people with acute aortic syndrome but without hyperlipidemia might benefit from statin treatment.
Trial Details
NCT Number NCT04699279
Lead Sponsor Nanjing Medical University
Collaborators: Beijing Anzhen Hospital, West China Hospital, The First Affiliated Hospital of Guangzhou Medical University, The Affiliated Hospital of Qingdao University Medical College
Conditions
(from sponsor)		 Acute Aortic Syndrome, Aortopathy
Related terms Acute Aortic Syndrome
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov